PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34278598-2	2021	This study aimed to explore the potential of gadolinium (Gd)-labelled cyclic peptides (pPB) targeting PDGF receptor-beta (PDGFR-beta) as a magnetic resonance imaging (MRI) radiotracer to identify the progression of liver fibrosis by imaging hepatic PDGFR-beta expression.	Gadolinium	45-55	platelet derived growth factor receptor, alpha polypeptide	Mus musculus	122-132	
34278598-2	2021	This study aimed to explore the potential of gadolinium (Gd)-labelled cyclic peptides (pPB) targeting PDGF receptor-beta (PDGFR-beta) as a magnetic resonance imaging (MRI) radiotracer to identify the progression of liver fibrosis by imaging hepatic PDGFR-beta expression.	Gadolinium	45-55	platelet derived growth factor receptor, alpha polypeptide	Mus musculus	249-259	
34278598-2	2021	This study aimed to explore the potential of gadolinium (Gd)-labelled cyclic peptides (pPB) targeting PDGF receptor-beta (PDGFR-beta) as a magnetic resonance imaging (MRI) radiotracer to identify the progression of liver fibrosis by imaging hepatic PDGFR-beta expression.	Gadolinium	57-59	platelet derived growth factor receptor, alpha polypeptide	Mus musculus	122-132	
34278598-2	2021	This study aimed to explore the potential of gadolinium (Gd)-labelled cyclic peptides (pPB) targeting PDGF receptor-beta (PDGFR-beta) as a magnetic resonance imaging (MRI) radiotracer to identify the progression of liver fibrosis by imaging hepatic PDGFR-beta expression.	Gadolinium	57-59	platelet derived growth factor receptor, alpha polypeptide	Mus musculus	249-259